Get the Stockscreener App
10.69
0.47%
0.05
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $10.69, with a volume of 2.71M.
It is up +0.47% in the last 24 hours and up +3.89% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$10.64
Open:
$10.65
24h Volume:
2.71M
Relative Volume:
0.29
Market Cap:
$12.31B
Revenue:
$14.33B
Net Income/Loss:
$-3.79B
P/E Ratio:
-3.3722
EPS:
-3.17
Net Cash Flow:
$1.84B
1W Performance:
+2.20%
1M Performance:
+3.89%
6M Performance:
+24.45%
1Y Performance:
-19.14%
1-Day Range:
$10.59
$10.71
1-Week Range:
$10.39
$10.73
52-Week Range:
$6.85
$13.24
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.69 | 12.25B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
128.18 | 56.27B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.42 | 45.87B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.78 | 43.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.89 | 30.20B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
486.00 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Initiated | Truist | Buy |
| Jun-06-25 | Initiated | Goldman | Neutral |
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
These 10 S&P 500 Stocks Are Dirt Cheap This Black Friday - Benzinga
Merz Loses Bid To Block Viatris In Unified Patent Court - Law360
What Do Recent Portfolio Streamlining Moves Mean for Viatris’s True Value in 2025? - Yahoo Finance
Merz fails with PI request in first ever SPC case against Viatris - JUVE Patent
Fondaparinux Market Set to Significantly Grow from 2025 to 2032 | - openPR.com
Viatris to Participate in Upcoming Investor Conferences - PR Newswire
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know - The Globe and Mail
Is Viatris Inc. (VIA) stock inflation resilientJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Can Viatris Inc. (VIA) stock sustain double digit ROETrade Risk Report & Long-Term Safe Investment Plans - newser.com
What market sentiment indicators show for Viatris Inc. (VIA) stockJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - newser.com
Can Viatris Inc. (VIA) stock test all time highsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
(VTRS) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Ex-Dividend Reminder: Viatris, Radian Group and Equitable Holdings - Nasdaq
European study shows falling prices, rising costs and shortagesfindings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe | Corporate - EQS News
Is Viatris Inc. stock supported by strong cash flowsInsider Buying & Comprehensive Market Scan Insights - newser.com
How Viatris Inc. (VIA) stock trades pre earningsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Europäische Studie zeigt sinkende Preise, steigende Kosten und EngpässeErgebnisse einer unabhängigen Studie, die während der World AMR Awareness Week von Viatris und Medicines for Europe vorgestellt wurden - PR Newswire
Is it time to cut losses on Viatris Inc.Weekly Trend Recap & Real-Time Stock Entry Alerts - newser.com
Is Viatris Inc. stock recession proof2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com
What technical charts say about Viatris Inc. stockJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Will Viatris Inc. (VIA) stock benefit from commodity supercycle2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Why Viatris Inc. stock could be next big winnerJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
Will Viatris Inc. stock recover faster than peersMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Can Viatris Inc. (VIA) stock surprise markets with earningsInflation Watch & Safe Entry Point Identification - newser.com
United States General Anesthesia Drugs Market Insights & Growth - openPR.com
What dividend safety score for Viatris Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Viatris Inc. stock outlook for YEARTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Using AI based signals to follow Viatris Inc.2025 Key Lessons & Real-Time Buy Zone Alerts - newser.com
Viatris Inc. - Ad-hoc-news.de
Viatris Inc. (0A5V.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Viatris Inc. stock a good choice for value investorsWeekly Risk Summary & Growth Focused Stock Reports - newser.com
What does recent volatility data suggest for Viatris Inc.Oil Prices & Growth Focused Stock Reports - newser.com
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.43%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):